Level 2

Company Announcements

Holding(s) in Company

Related Companies

By LSE RNS

RNS Number : 0755X
Spire Healthcare Group PLC
16 February 2017
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii

Spire Healthcare Group plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

X

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):


3. Full name of person(s) subject to the
notification obligation: iii

The Goldman Sachs Group, Inc.

4. Full name of shareholder(s)
 (if different from 3.):iv

Goldman Sachs International

Goldman, Sachs & Co.

GS Investment Strategies, LLC

5. Date of the transaction and date on
which the threshold is crossed or
reached: v

13 February 2017

6. Date on which issuer notified:

15 February 2017

7. Threshold(s) that is/are crossed or
reached: vi, vii

Above 3%


 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

GB00BNLPYF73

Below 3%

Below 3%



6,946,370


1.732%



B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date xiii

Exercise/
Conversion Period xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

Stock Loan (Physical)

Open


5,097,404

1.271%

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta








Total (A+B+C)

Number of voting rights

Percentage of voting rights

12,043,774

3.003%


 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi

 

-----------------The Goldman Sachs Group, Inc.; 12,043,774 shares; 3.003%

 

Goldman Sachs (UK) L.L.C. (Controlled by The Goldman Sachs Group, Inc.)

Goldman Sachs Group UK Limited (Controlled by Goldman Sachs (UK) L.L.C.)

Goldman Sachs International (Controlled by Goldman Sachs Group UK Limited)

 

The Goldman, Sachs & Co. L.L.C. (Controlled by The Goldman Sachs Group, Inc.)

Goldman, Sachs & Co. (Controlled by The Goldman, Sachs & Co. L.L.C.)

 

GSAM Holdings LLC (Controlled by The Goldman Sachs Group, Inc.)

GS Investment Strategies, LLC (Controlled by GSAM Holdings LLC)

 


Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease
to hold:

N/A

12. Date on which proxy holder will cease to hold
voting rights:

N/A



13. Additional information:

Please note, total amount of voting rights have been rounded to 3 decimal places therefore there is a possibility of a rounding error.

 

General email contact:

shareholderdisclosures@gs.com

 

14. Contact name:

Joanna Foley

15. Contact telephone number:


+44 207 051 9996

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUNVKRBNAUARR

Top of Page